Skip to main content
SpringerLink
Log in

Diagnostica per immagini: fegato e vie biliari

  • Chapter
Ecografia e procedure interventistiche percutanee

  • 506 Accesses

Estratto

Il fegato rappresenta uno degli organi maggiormente studiati in diagnostica per immagini. Le procedure interventistiche percutanee imaging-guidate sono spesso presenti nell’iter diagnostico e terapeutico della patologia epatica. Quando e perché ricorrere alle procedure interventistiche percutanee per la diagnosi ed il trattamento della patologia epatica viene correttamente stabilito se risultano accurate la caratte-rizzazione ed il bilancio di malattia (planning pre-procedura) alla diagnostica per immagini, che viene utilizzata anche per i successivi controlli (follow-up).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.95
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliografia

  1. Claudon M, Cosgrove D, Albrecht T et al (2008) Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS)-update 2008. Ultraschall Med 29:28–44

    Article  PubMed  CAS  Google Scholar 

  2. Forner A, Vilana R, Ayuso C et al (2008) Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology 47:97–104

    Article  PubMed  Google Scholar 

  3. Faccioli N, D’onofrio M, Comai A, Cugini C (2007) Contrast-enhanced ultrasonography in the characterization of benign focal liver lesions: activity-based cost analysis. Radiol Med 112:810–820

    Article  CAS  PubMed  Google Scholar 

  4. Kamel IR, Choti MA, Horton KM et al (2003) Surgically staged focal liver lesions: accuracy and reproducibility of dual-phase helical CT for detection and characterization. Radiology 227:752–757

    Article  PubMed  Google Scholar 

  5. Bruix J, Sherman M, Llovet JM et al (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference. Journal of Hepatology 35:421–430

    Article  PubMed  CAS  Google Scholar 

  6. Jang HJ, Lim JH, Lee SJ et al (2000) Hepatocellular carcinoma: are combined CT during arterial portography and CT hepatic arteriography in addition to triple-phase helical CT all necessary for preoperative evaluation? Radiology 15:373–380

    Google Scholar 

  7. Kang BK, Lim JH, Kim SH et al (2003) Preoperative depiction of hepatocellular carcinoma: ferumoxides-enhanced MR imaging versus triple-phase helical CT. Radiology 226:79–85

    Article  PubMed  Google Scholar 

  8. Lim JH, Park CK (2004) Hepatocellular carcinoma in advanced liver cirrhosis: CT detection in transplant patients. Abdom Imaging 29:203–207

    Article  PubMed  CAS  Google Scholar 

  9. Murakami T, Baron RL, Peterson MS et al (1996) Hepatocellular carcinoma: MR imaging with Mangafodipir trisodium (Mn-DPDP). Radiology 200:69–77

    PubMed  CAS  Google Scholar 

  10. Rofsky NM, Weinreb JC, Bernardino ME et al (1993) Hepatocellular tumors: characterization with Mn-DPDP-enhanced MR imaging. Radiology 188:53–59

    PubMed  CAS  Google Scholar 

  11. Manfredi R, Maresca G, Baron RL et al (1999) Delayed MR imaging of hepatocellular carcinoma enhanced by gadobenate dimeglumine (Gd-BOPTA). J Magn Reson Imaging 9:704–710

    Article  PubMed  CAS  Google Scholar 

  12. Huppertz A, Haraida S, Kraus A et al (2005) Enhancement of focal liver lesions at gadoxetic acidenhanced MR imaging: correlation with histopathologic findings and spiral CT—initial observations. Radiology 234:468–478

    Article  PubMed  Google Scholar 

  13. Eubank WB, Wherry KL, Maki JH et al (2002) Preoperative evaluation of patients awaiting liver transplantation: comparison of multiphasic contrast-enhanced 3D magnetic resonance to helical Computed Tomography examinations. J Magn Reson Imaging 16:565–575

    Article  PubMed  Google Scholar 

  14. Mori K, Scheidler J, Helmberger T et al (2002) Detection of malignant hepatic lesions before orthotopic liver transplantation: accuracy of ferumoxides-enhanced MR imaging. AJR Am J Roentgenol 179:1045–1051

    PubMed  Google Scholar 

  15. Rode A, Bancel B, Douek P et al (2001) Small nodule detection in cirrhotic livers: evaluation with US, spiral CT, and MRI and correlation with pathologic examination of explanted liver. J Comput Assist Tomogr 25:327–336

    Article  PubMed  CAS  Google Scholar 

  16. Krinsky GA, Lee VS, Theise ND et al (2001) Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: prospective diagnosis with MR imaging and explantation correlation. Radiology 219:445–454

    PubMed  CAS  Google Scholar 

  17. Holland AE, Hecht EM, Hahn WY et al (2005) Importance of small (< or = 20 mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver. Radiology 237:938–944

    Article  PubMed  Google Scholar 

  18. Kim YK, Kwak HS, Kim CS et al (2006) Hepatocellular Carcinoma in Patients with Chronic Liver Disease: Comparison of SPIO-enhanced MR Imaging and 16-Detector Row CT. Radiology 238:531–541

    Article  PubMed  Google Scholar 

  19. Schneider G, Grazioli L, Saini S (2003) Contrast Agents for liver MR Imaging in: MRI of the liver. Springer, Berlin Heidelberg, New York

    Google Scholar 

  20. Schroeder T, Malago M, Debatin JF et al (2005) “All-in-one” imaging protocols for the evaluation of potential living liver donors: comparison of magnetic resonance imaging and multidetector computed tomography. Liver Transpl 11:776–787

    Article  PubMed  Google Scholar 

  21. Taourel P, Bret PM, Reinhold C et al (1996) Anatomic variants of the biliary tree: diagnosis with MR cholangiopancreatography. Radiology 199:521–527

    PubMed  CAS  Google Scholar 

  22. Petersein J, Spinazzi A, Giovagnoni A et al (2000) Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging-a multicenter phase III clinical study. Radiology 215:727–736

    PubMed  CAS  Google Scholar 

  23. Spinazzi A, Lorusso V, Pirovano G et al (1999) Safety, tolerance, biodistribution and MR imaging enhancement of the liver with gadobenate dimeglumine: results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers. Acad Radiol 6:282–292

    Article  PubMed  CAS  Google Scholar 

  24. Lim JS, Kim MJ, Jung YY, Kim KW (2005) Gadobenate dimeglumine as an intrabiliary contrast agent: comparison with mangafodipir trisodium with respect to non-dilated biliary tree depiction. Korean J Radiol 6:229–34

    Article  PubMed  Google Scholar 

  25. Lencioni R, Crocetti L (2007) Radiofrequency ablation of liver cancer. Tech Vasc Interv Radiol 10:38–46

    Article  PubMed  Google Scholar 

  26. Guglielmi A, Ruzzenente A, Valdegamberi A et al (2008) Radiofrequency ablation versus surgical resection for treatment of hepatocellular carcinoma in cirrhosis. J Grastrointest Surg 12:192–198

    Article  Google Scholar 

  27. Karahan OI, Yikilmaz A, Isin S, Orhan S (2003) Characterization of hepatocellular carcinomas with triphasic CT and correlation with histopathologic findings. Acta Radiol 44:566–571

    Article  PubMed  CAS  Google Scholar 

  28. Baron RL, Brancatelli G (2004) Computed Tomographic imaging of hepatocellular carcinoma. Gastroenterol 127:133–143

    Article  Google Scholar 

  29. Livraghi T, Festi D, Monti F et al (1986) US-guided percutaneous alcohol injection of small hepatic and abdominal tumors. Radiology 61:309–312

    Google Scholar 

  30. Giovannini M (2002) Percutaneous alcohol ablation for liver metastasis. Semin Oncol. 29:192–195

    Article  PubMed  Google Scholar 

  31. Lencioni R, Crocetti L (2005) Radiofrequency ablation. In: vanSonnenberg E, McMullen W, Solbiati S (eds) Tumor Ablation. Springer, Berlin, Heidelberg, New York, pp 205–218

    Chapter  Google Scholar 

  32. Livraghi T, Bolondi L, Buscarini L et al (1995) No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis. Italian Cooperative HCC Study Group. J Hepatol 22:522–526

    Article  PubMed  CAS  Google Scholar 

  33. Shiina S, Tagawa K, Unuma T et al (1991) Percutaneous ethanol injection therapy for hepatocellular carcinoma. A histopathologic study. Cancer 68:1524–1530

    Article  PubMed  CAS  Google Scholar 

  34. Orlando A, Cottone M, Virdone R et al (2003) Treatment of small hepatocellular carcinoma associated with cirrhosis by percutaneous ethanol injection. A trial with a comparison group. Scand J Gastroenterol 32:598–603

    Article  Google Scholar 

  35. Vivarelli M, Guglielmi A, Ruzzenente A et al (2004) Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver. Ann Surg 240:102–107

    Article  PubMed  Google Scholar 

  36. Guglielmi A, Ruzzenente A, Valdegamberi A et al (2008) Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma in cirrhosis. J Gastrointest Surg 12:192–198

    Article  PubMed  Google Scholar 

  37. Lencioni R, Cioni D, Crocetti L et al (2005) Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 234:961–967

    Article  PubMed  Google Scholar 

  38. Hanbidge AE, Buckler PM, O’Malley ME, Wilson SR (2004) From the RSNA refresher courses: imaging evaluation for acute pain in the right upper quadrant. RadioGraphics 24:1117–1135

    Article  PubMed  Google Scholar 

  39. Menu Y, Vuillerme MP (2002) Non-traumatic abdominal emergencies: imaging and intervention in acute biliary conditions. Eur Radiol 12:2397–2406

    PubMed  Google Scholar 

  40. Sugiyama M, Atomi Y (2002) Risk factors predictive of late complications after endoscopic sphincterotomy for bile duct stones: long-term (more than 10 years) follow-up study. Am J Gastroenterol 97:2763–2767

    Article  PubMed  Google Scholar 

  41. Bolondi L, Correas JM, Lencioni R et al (2007) New perspectives for the use of contrast-enhanced liver ultrasound in clinical practice. Dig Liver Dis 39:187–195

    Article  PubMed  CAS  Google Scholar 

  42. Vilana R, Bianchi L, Varela M et al (2006) Is microbubble-enhanced ultrasonography sufficient for assessment of response to percutaneous treatment in patients with early hepatocellular carcinoma? Eur Radiol 16:2454–2462

    Article  PubMed  CAS  Google Scholar 

  43. Solbiati L, Ierace T, Tonolini M, Cova L (2004) Guidance and monitoring of radiofrequency liver tumor ablation with contrast-enhanced ultrasound. Eur J Radiol 51[Suppl]:S19–23

    Article  PubMed  Google Scholar 

  44. Gazelle GS, Goldberg SN, Solbiati L, Livraghi T (2000) Tumor ablation with radio-frequency energy. Radiology 217:633–646

    PubMed  CAS  Google Scholar 

  45. Lim HK, Han JK (2002) Hepatocellular carcinoma: evaluation of therapeutic response to interventional procedures. Abdom Imaging 27:168–179

    Article  PubMed  CAS  Google Scholar 

  46. Lim HK, Choi D, Lee WJ et al (2001) Hepatocellular carcinoma treated with percutaneous radiofrequency ablation: evaluation with follow-up multiphase helical CT. Radiology 221:447–454

    Article  PubMed  CAS  Google Scholar 

  47. Mitsuzaki K, Yamashita Y, Nishiharu T et al (1998) CT appearance of hepatic tumors after microwave coagulation therapy. AJR Am J Roentgenol 171:1397–1403

    PubMed  CAS  Google Scholar 

  48. Bartolozzi C, Lencioni R, Caramella D et al (1994) Hepatocellular carcinoma: CT and MR features after transcatheter arterial embolization and percutaneous ethanol injection. Radiology 191:123–128

    PubMed  CAS  Google Scholar 

  49. Ebara M, Kita K, Sugiura N et al (1995) Therapeutic effect of percutaneous ethanol injection on small hepatocellular carcinoma: evaluation with CT. Radiology 195:371–377

    PubMed  CAS  Google Scholar 

  50. Kim SK, Lim HK, Kim YH et al (2003) Hepatocellular carcinoma treated with radio-frequency ablation: spectrum of imaging findings. RadioGraphics 23:107–121

    Article  PubMed  Google Scholar 

  51. Sironi S, Livraghi T, Meloni F et al (1999) Small hepatocellular carcinoma treated with percutaneous RF ablation: MR imaging follow-up. AJR Am J Roentgenol 173:1225–1229

    PubMed  CAS  Google Scholar 

  52. Guglielmi A, Ruzzenente A, Sandri M et al (2007) Radio frequency ablation for hepatocellular carcinoma in cirrhotic patients: prognostic factors for survival. J Gastrointest Surg 11:143–149

    Article  PubMed  Google Scholar 

  53. Lencioni R, Crocetti L, Cioni D et al (2004) Percutaneous radiofrequency ablation of hepatic colorectal metastases: technique, indications, results, and new promises. Invest Radiol 39:689–697

    Article  PubMed  Google Scholar 

  54. Gillams AR, Lees WR (2004) Radio-frequency ablation of colorectal liver metastases in 167 patients. Eur Radiol 14:2261–2267

    Article  PubMed  CAS  Google Scholar 

  55. Berber E, Pelley R, Siperstein AE (2005) Predictors of survival after radiofrequency thermal ablation of colorectal cancer metastases to the liver: a prospective study. J Clin Oncol 23:1358–1364

    Article  PubMed  Google Scholar 

  56. Lencioni R, Cioni D, Crocetti L et al (2005) Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 234:961–967

    Article  PubMed  Google Scholar 

  57. Tateishi R, Shiina S, Teratani T et al (2005) Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 103:1201–1209

    Article  PubMed  Google Scholar 

  58. Cabassa P, Donato F, Simeone F et al (2006) Radiofrequency ablation of hepatocellular carcinoma: long-term experience with expandable needle electrodes. AJR Am J Roentgenol 186:S316–321

    Article  PubMed  Google Scholar 

  59. Choi D, Lim HK, Rhim H et al (2007) Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series EurRadiol 17:684–692

    Google Scholar 

  60. Solbiati L, Livraghi T, Goldberg SN et al (2001) Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 221:159–166

    Article  PubMed  CAS  Google Scholar 

  61. Jakobs TF, Hoffmann RT, Trumm C et al (2006) Radiofrequency ablation of colorectal liver metastases: mid-term results in 68 patients. Anticancer Res 26:671–680

    PubMed  Google Scholar 

  62. Sørensen SM, Mortensen FV, Nielsen DT (2007) Radiofrequency ablation of colorectal liver metastases: long-term survival. Acta Radiol 48:253–258

    Article  PubMed  Google Scholar 

  63. Sugiyama M, Atomi Y, Singh A et al (2006) Imaging-guided catheter drainage of abdominal collections with fistulous pancreaticobiliary communication. AJR Am J Roentgenol 187:1591–1596

    Article  Google Scholar 

Download references

Authors
  1. Roberto Malagò
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Riccardo Manfredi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer

About this chapter

Cite this chapter

Malagò, R., Manfredi, R. (2008). Diagnostica per immagini: fegato e vie biliari. In: Ecografia e procedure interventistiche percutanee. Springer, Milano. https://doi.org/10.1007/978-88-470-1062-8_6

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-1062-8_6

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-1061-1

  • Online ISBN: 978-88-470-1062-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation